VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 56 filers reported holding VENTYX BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,716,788 | +11.4% | 2,957,581 | +5.2% | 0.02% | +15.8% |
| Q2 2023 | $92,234,650 | -9.2% | 2,812,032 | -7.3% | 0.02% | -13.6% |
| Q1 2023 | $101,629,721 | -18.2% | 3,033,723 | -20.0% | 0.02% | -24.1% |
| Q4 2022 | $124,282,068 | +1.5% | 3,790,243 | +8.0% | 0.03% | +3.6% |
| Q3 2022 | $122,501,000 | +157.4% | 3,509,064 | -9.8% | 0.03% | +133.3% |
| Q2 2022 | $47,591,000 | -7.4% | 3,891,328 | -0.5% | 0.01% | +9.1% |
| Q1 2022 | $51,377,000 | -31.3% | 3,911,910 | +0.5% | 0.01% | -26.7% |
| Q4 2021 | $74,736,000 | – | 3,891,028 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 3,461,536 | $113,503,765 | 35.19% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $24,473,472 | 32.37% |
| Vivo Capital, LLC | 1,303,294 | $42,735 | 4.92% |
| ACUTA CAPITAL PARTNERS, LLC | 290,500 | $7,558,095 | 4.65% |
| TCG Crossover Management, LLC | 787,231 | $25,813,304 | 4.56% |
| Affinity Asset Advisors, LLC | 240,623 | $7,890,028 | 3.09% |
| GREAT POINT PARTNERS LLC | 400,695 | $13,138,789 | 2.58% |
| Logos Global Management LP | 657,016 | $21,543,555 | 2.52% |
| Cormorant Asset Management, LP | 1,080,643 | $35,434 | 2.37% |
| Boxer Capital, LLC | 850,000 | $27,871,500 | 1.47% |